The Valley Desk

NCT05803421 · Interventional trial

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Overall registry status Completed

Phase 3

Conditions Cardiovascular Diseases, Chronic Kidney Disease, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov